tradingkey.logo

Teleflex Inc

TFX
122.240USD
-0.050-0.04%
收盤 12/24, 16:00美東報價延遲15分鐘
5.40B總市值
虧損本益比TTM

Teleflex Inc

122.240
-0.050-0.04%

關於 Teleflex Inc 公司

Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.

Teleflex Inc簡介

公司代碼TFX
公司名稱Teleflex Inc
上市日期Mar 17, 1980
CEOKelly (Liam J)
員工數量14100
證券類型Ordinary Share
年結日Mar 17
公司地址550 E Swedesford Rd
城市WAYNE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編19087
電話16102256800
網址https://www.teleflex.com/usa/en/#
公司代碼TFX
上市日期Mar 17, 1980
CEOKelly (Liam J)

Teleflex Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
其他
136.24M
17.45%
地區USD
名稱
營收
佔比
Americas
525.64M
67.31%
EMEA
166.23M
21.29%
Asia Pacific
89.03M
11.40%
業務
地區
業務USD
名稱
營收
佔比
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
其他
136.24M
17.45%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
其他
53.03%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
其他
53.03%
股東類型
持股股東
佔比
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
36.75%
Hedge Fund
9.11%
Pension Fund
1.76%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.57%
Family Office
0.37%
Individual Investor
0.34%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.97M
11.25%
-385.28K
-7.19%
Jun 30, 2025
The Vanguard Group, Inc.
4.80M
10.86%
-269.49K
-5.32%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
5.94M
13.45%
-272.00K
-4.38%
Jun 30, 2025
Janus Henderson Investors
4.15M
9.39%
-176.31K
-4.08%
Jun 30, 2025
AQR Capital Management, LLC
409.32K
0.93%
+116.80K
+39.93%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
2.40M
5.44%
-373.80K
-13.46%
Jun 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-69.05K
-4.52%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.24M
2.81%
+373.94K
+43.09%
Jun 30, 2025
Cooke & Bieler, L.P.
1.21M
2.73%
+148.44K
+14.04%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比3.37%
First Trust Indxx Medical Devices ETF
佔比2.09%
First Trust Health Care Alphadex Fund
佔比1.77%
State Street SPDR S&P Health Care Equipment ETF
佔比1.7%
Zacks Small/Mid Cap ETF
佔比0.85%
State Street SPDR S&P 600 Small Cap Value ETF
佔比0.75%
iShares S&P Small-Cap 600 Value ETF
佔比0.75%
Distillate Small/Mid Cash Flow ETF
佔比0.7%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
佔比0.67%

分紅派息

近5年累計派現 318.10M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Teleflex Inc的前五大股東是誰?

Teleflex Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:4.97M
佔總股份比例:11.25%。
The Vanguard Group, Inc.
持有股份:4.80M
佔總股份比例:10.86%。
T. Rowe Price Investment Management, Inc.
持有股份:5.94M
佔總股份比例:13.45%。
Janus Henderson Investors
持有股份:4.15M
佔總股份比例:9.39%。
AQR Capital Management, LLC
持有股份:409.32K
佔總股份比例:0.93%。

Teleflex Inc的前三大股東類型是什麼?

Teleflex Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.

有多少機構持有Teleflex Inc(TFX)的股份?

截至2025Q3,共有1153家機構持有Teleflex Inc的股份,合計持有的股份價值約為47.10M,占公司總股份的106.58% 。與2025Q2相比,機構持股有所增加,增幅為-3.56%。

哪個業務部門對Teleflex Inc的收入貢獻最大?

在FY2025Q2,Vascular access業務部門對Teleflex Inc的收入貢獻最大,創收185.53M,占總收入的23.76% 。
KeyAI